This activity is accredited for immunization credit.
Program Description
Vaccine hesitancy remains a significant public health challenge in the United States, especially with the evolution of new vaccine technologies such as mRNA platforms. Despite scientific advancements, skepticism persists among patients and health care providers. Pharmacists are uniquely positioned to address these misconceptions and promote public acceptance. The panelists will facilitate a discussion focusing on the latest scientific developments, regulatory guidelines, and best practices in immunization with mRNA technologies specifically. The program will delve into the historical context of vaccine development, highlighting the benefits and core mechanisms of mRNA technology. The strategic applications of mRNA technologies, including pandemic preparedness and therapeutic expansion, will be discussed alongside current and emerging mRNA vaccines. Panelists will also address commonly asked questions and provide pharmacists with resources and strategies to effectively communicate with patients, dispel misconceptions, and reduce barriers to vaccination.
Target audience: Community pharmacists, health- system
pharmacists, and pharmacy technicians
Type of
activity: Application
Release date: October 3, 2025
Expiration date: October 3, 2026
Time to complete activity: 1.5 hours
Learner level: Intermediate,
Advanced
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain mRNA technology and its application in vaccine development
- Identify and correct common myths and misconceptions held by patients and health care professionals about mRNA vaccines
- Use communication strategies and clinical tools to counsel patients effectively and build vaccine confidence
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here